返回
Ludwig Enterprises Inc（LUDG）價格
LUDG 股價走勢圖
LUDG 收益
Ludwig Enterprises Inc
$0.07
0%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$0.07
0%
$0
盤前：Jan 20, 08:21:38 GMT-5
關鍵數據
前收市價
$0.07
開盤價
$0.07
當日範圍
$0.07 - $0.07
52週區間
$0.042 - $0.168
交易量
11.0K
平均成交量
5.5K
每股盈餘 (TTM)
--
股息收益率
--
市值
$22.1M
什麼是 LUDG？
Ludwig Enterprises Inc, operates as a biotech and healthcare holding company. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2007-12-11. Its proprietary mRNA genomic technology has the potential of screening for genetic biomarkers for inflammatory-driven diseases, including, but not limited to, heart disease, diabetes, preeclampsia, cancer and long COVID. The firm employs a non-invasive cheek swab test to collect mRNA samples. Its initial product candidate is the Revealia Breast test, a non-invasive cheek swab assay designed to detect molecular signatures in mRNA expression associated with the presence of breast cancer. Its technology platform integrates three key components: non-invasive sample collection, genomic analysis, and machine learning-based interpretation.
